ofloxacin ( 300 mg twice a day ) and trimethoprim-sulfamethoxazole ( tmp-smz ) ( 160 mg trimethoprim and 800 mg sulfamethoxazole twice a day ) were given prophylactically to 19 adult patients with acute leukemia undergoing induction chemotherapy .
C0041044
trimethoprim-sulfamethoxazole
C0038689
sulfamethoxazole